Paired tumor sequencing and germline testing in breast cancer management: An experience of a single academic center-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Paired tumor sequencing and germline testing in breast cancer management: An experience of a single academic center

Published:2020-09-03 Issue:6 Volume:3 Page:
ISSN:2573-8348
Container-title:Cancer Reports
language:en
Short-container-title:Cancer Reports

Author:

Elliott Elizabeth¹,Speare Virginia²,Coggan James¹^ORCID,Espenschied Carin²,LaDuca Holly²,Yussuf Amal F.²,Burgess Kelly¹,Gray Phillip²,Cobleigh Melody¹,Rao Ruta¹,Patel Jeremy¹,Kuzel Timothy¹,Buckingham Lela E.³,Usha Lydia¹

Affiliation:

1. Department of Medicine, Division of Hematology, Oncology, and Stem Cell Transplant Medicine Rush University Medical Center Chicago IL USA

2. Ambry Genetics Aliso Viejo California USA

3. Department of Pathology Rush University Medical Center Chicago IL

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1287

Reference54 articles.

1. Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

2. Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials

3. Targeted therapy in cancer

4. Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

5. Administration U.S.F.D. (2018) Fda approves olaparib for germline brca‐mutated metastatic breast cancer.https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm592357.htm. Accessed April 16 2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP